Zhejiang Nhu Co Ltd
SZSE:002001

Watchlist Manager
Zhejiang Nhu Co Ltd Logo
Zhejiang Nhu Co Ltd
SZSE:002001
Watchlist
Price: 25.55 CNY -1.5% Market Closed
Market Cap: 78.5B CNY

Relative Value

The Relative Value of one Zhejiang Nhu Co Ltd stock under the Base Case scenario is hidden CNY. Compared to the current market price of 25.55 CNY, Zhejiang Nhu Co Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Zhejiang Nhu Co Ltd Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
55
vs Industry
34
Median 3Y
3.4
Median 5Y
3.6
Industry
2.7
Forward
3.3
vs History
82
vs Industry
31
Median 3Y
15.9
Median 5Y
16.6
Industry
21.6
Forward
12
vs History
76
vs Industry
39
Median 3Y
10.1
Median 5Y
11.6
Industry
16.9
vs History
71
vs Industry
22
Median 3Y
14.4
Median 5Y
24
Industry
22.9
vs History
36
vs Industry
30
Median 3Y
2.3
Median 5Y
2.5
Industry
2.3
vs History
73
vs Industry
34
Median 3Y
3.5
Median 5Y
3.7
Industry
3
Forward
3.1
vs History
79
vs Industry
23
Median 3Y
10.1
Median 5Y
10.5
Industry
5.6
vs History
80
vs Industry
29
Median 3Y
13.9
Median 5Y
14.3
Industry
13.4
Forward
7.8
vs History
80
vs Industry
33
Median 3Y
13.9
Median 5Y
14.3
Industry
16.7
Forward
10
vs History
80
vs Industry
39
Median 3Y
10.6
Median 5Y
12.5
Industry
16.1
vs History
58
vs Industry
27
Median 3Y
11.5
Median 5Y
20.4
Industry
18.9
vs History
33
vs Industry
33
Median 3Y
1.9
Median 5Y
2.1
Industry
2

Multiples Across Competitors

Competitors Multiples
Zhejiang Nhu Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Zhejiang Nhu Co Ltd
SZSE:002001
78.2B CNY 3.5 10.9 9 9
US
Eli Lilly and Co
NYSE:LLY
1T USD 16.9 54.6 36.7 39.3
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
491.8B USD 5.3 19.6 16 20.8
CH
Roche Holding AG
SIX:ROG
271.4B CHF 4.4 28.8 12.2 14.3
UK
AstraZeneca PLC
LSE:AZN
220.4B GBP 5.1 31.4 108.8 159.2
US
Merck & Co Inc
NYSE:MRK
274.9B USD 4.3 14.4 10.2 12.1
CH
Novartis AG
SIX:NOVN
218.8B CHF 4.9 19 12 15.5
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK 5.4 16.3 11.3 13.2
IE
Endo International PLC
LSE:0Y5F
213.9B USD 92.2 -73.2 338.7 849.2
US
Pfizer Inc
NYSE:PFE
144.9B USD 2.3 14.7 7.5 10.2
P/E Multiple
Earnings Growth PEG
CN
Zhejiang Nhu Co Ltd
SZSE:002001
Average P/E: 23.3
10.9
9%
1.2
US
Eli Lilly and Co
NYSE:LLY
54.6
54%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
19.6
29%
0.7
CH
Roche Holding AG
SIX:ROG
28.8
29%
1
UK
AstraZeneca PLC
LSE:AZN
31.4
37%
0.8
US
Merck & Co Inc
NYSE:MRK
14.4
15%
1
CH
Novartis AG
SIX:NOVN
19
17%
1.1
DK
Novo Nordisk A/S
CSE:NOVO B
16.3
3%
5.4
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -73.2 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.7
27%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CN
Zhejiang Nhu Co Ltd
SZSE:002001
Average EV/EBITDA: 400.8
9
15%
0.6
US
Eli Lilly and Co
NYSE:LLY
36.7
34%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16
9%
1.8
CH
Roche Holding AG
SIX:ROG
12.2
5%
2.4
UK
AstraZeneca PLC
LSE:AZN
108.8
10%
10.9
US
Merck & Co Inc
NYSE:MRK
10.2
6%
1.7
CH
Novartis AG
SIX:NOVN
12
6%
2
DK
Novo Nordisk A/S
CSE:NOVO B
11.3
1%
11.3
IE
E
Endo International PLC
LSE:0Y5F
338.7
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.5
0%
N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CN
Zhejiang Nhu Co Ltd
SZSE:002001
Average EV/EBIT: 1 713.2
9
6%
1.5
US
Eli Lilly and Co
NYSE:LLY
39.3
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
20.8
15%
1.4
CH
Roche Holding AG
SIX:ROG
14.3
6%
2.4
UK
AstraZeneca PLC
LSE:AZN
159.2
23%
6.9
US
Merck & Co Inc
NYSE:MRK
12.1
8%
1.5
CH
Novartis AG
SIX:NOVN
15.5
12%
1.3
DK
Novo Nordisk A/S
CSE:NOVO B
13.2
0%
N/A
IE
E
Endo International PLC
LSE:0Y5F
849.2
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.2
7%
1.5